Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,975 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting by Pharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway.
von Witzleben A, Goerttler LT, Marienfeld R, Barth H, Lechel A, Mellert K, Böhm M, Kornmann M, Mayer-Steinacker R, von Baer A, Schultheiss M, Flanagan AM, Möller P, Brüderlein S, Barth TF. von Witzleben A, et al. Among authors: moller p. Cancer Res. 2015 Sep 15;75(18):3823-31. doi: 10.1158/0008-5472.CAN-14-3270. Epub 2015 Jul 16. Cancer Res. 2015. PMID: 26183925
HOXA7, HOXA9, and HOXA10 are differentially expressed in clival and sacral chordomas.
Jäger D, Barth TFE, Brüderlein S, Scheuerle A, Rinner B, von Witzleben A, Lechel A, Meyer P, Mayer-Steinacker R, Baer AV, Schultheiss M, Wirtz CR, Möller P, Mellert K. Jäger D, et al. Among authors: moller p. Sci Rep. 2017 May 17;7(1):2032. doi: 10.1038/s41598-017-02174-5. Sci Rep. 2017. PMID: 28515451 Free PMC article.
Molecular features and vulnerabilities of recurrent chordomas.
Seeling C, Lechel A, Svinarenko M, Möller P, Barth TFE, Mellert K. Seeling C, et al. Among authors: moller p. J Exp Clin Cancer Res. 2021 Jul 30;40(1):244. doi: 10.1186/s13046-021-02037-y. J Exp Clin Cancer Res. 2021. PMID: 34330313 Free PMC article.
Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib.
Böhm MJ, Marienfeld R, Jäger D, Mellert K, von Witzleben A, Brüderlein S, Wittau M, von Baer A, Schultheiss M, Mayer-Steinacker R, Rücker FG, Möller P, Bullinger L, Barth TFE. Böhm MJ, et al. Among authors: moller p. Sarcoma. 2019 Jan 21;2019:3914232. doi: 10.1155/2019/3914232. eCollection 2019. Sarcoma. 2019. PMID: 30804704 Free PMC article.
Immunohistochemical and FISH analysis of MDM2 and CDK4 in a dedifferentiated extraskeletal osteosarcoma arising in the vastus lateralis muscle: differential diagnosis and diagnostic algorithm.
von Baer A, Ehrhardt A, Baumhoer D, Mayer-Steinacker R, Schultheiss M, Abdul-Nou T, Mentzel T, Fend F, Möller P, Jundt G, Barth TF. von Baer A, et al. Among authors: moller p. Pathol Res Pract. 2014 Oct;210(10):698-703. doi: 10.1016/j.prp.2014.05.010. Epub 2014 May 22. Pathol Res Pract. 2014. PMID: 24974983
Profiling of three H3F3A-mutated and denosumab-treated giant cell tumors of bone points to diverging pathways during progression and malignant transformation.
Hasenfratz M, Mellert K, Marienfeld R, von Baer A, Schultheiss M, Roitman PD, Aponte-Tinao LA, Lehner B, Möller P, Mechtersheimer G, Barth TFE. Hasenfratz M, et al. Among authors: moller p. Sci Rep. 2021 Mar 11;11(1):5709. doi: 10.1038/s41598-021-85319-x. Sci Rep. 2021. PMID: 33707617 Free PMC article.
1,975 results